We are live on ! Find out more
RCP

Rothschild Capital Partners Portfolio holdings

AUM $408M
1-Year Est. Return 25.87%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+25.87%
3 Year Est. Return
+81.82%
5 Year Est. Return
+111.3%
10 Year Est. Return
+529.64%
AUM
$232M
AUM Growth
+$8.04M
Cap. Flow
-$626K
Cap. Flow %
-0.27%
Top 10 Hldgs %
52.2%
Holding
52
New
11
Increased
12
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
CSII
Cardiovascular Systems, Inc.
CSII
+$6.58M
2
EPC icon
Edgewell Personal Care
EPC
+$5.68M
3
CTXS
Citrix Systems Inc
CTXS
+$5.6M
4
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$4.78M
5
HEDJ icon
WisdomTree Europe Hedged Equity Fund
HEDJ
+$3.97M

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$12.8M
2
STWD icon
Starwood Property Trust
STWD
+$6.82M
3
TMO icon
Thermo Fisher Scientific
TMO
+$5.44M
4
DXCM icon
DexCom
DXCM
+$5.02M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.25M

Sector Composition

Rank Sector Weight
1 Healthcare 20.17%
2 Technology 19.66%
3 Communication Services 11.92%
4 Energy 7.18%
5 Industrials 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XEC
26
DELISTED
CIMAREX ENERGY CO
XEC
$3.77M 1.63%
34,175
– –
EWG icon
27
iShares MSCI Germany ETF
EWG
$1.61B
$2.93M 1.26%
104,960
+3,260
+3% +$96.8K
CGNT
28
DELISTED
Cogentix Medical, Inc.
CGNT
$705K 0.3%
+435,340
New +$713K
RHT
29
DELISTED
Red Hat Inc
RHT
$605K 0.26%
7,966
– –
HD icon
30
Home Depot
HD
$349B
$567K 0.24%
5,100
– –
CUTR
31
DELISTED
Cutera, Inc.
CUTR
$558K 0.24%
36,050
– –
PFPT
32
DELISTED
Proofpoint, Inc.
PFPT
$521K 0.22%
+8,180
New +$481K
AVG
33
DELISTED
AVG Technologies N.V.
AVG
$515K 0.22%
+18,940
New +$461K
BLOX
34
DELISTED
Infoblox Inc
BLOX
$512K 0.22%
+19,550
New +$493K
BIIB icon
35
CALL
Biogen
BIIB
$30.5B
$404K 0.17%
+1,000
New +$401K
ALR
36
DELISTED
Alere Inc
ALR
$400K 0.17%
7,580
+880
+13% +$44.3K
TMO icon
37
Thermo Fisher Scientific
TMO
$214B
$357K 0.15%
2,750
-41,754
-94% -$5.44M
XOM icon
38
ExxonMobil
XOM
$642B
$311K 0.13%
3,735
-1,450
-28% -$125K
DGX icon
39
Quest Diagnostics
DGX
$26.3B
$273K 0.12%
3,764
– –
JNJ icon
40
Johnson & Johnson
JNJ
$619B
$242K 0.1%
2,486
+400
+19% +$40.1K
NSC icon
41
Norfolk Southern
NSC
$76.9B
$238K 0.1%
2,729
– –
GILD icon
42
CALL
Gilead Sciences
GILD
$162B
$234K 0.1%
+2,000
New +$219K
PG icon
43
Procter & Gamble
PG
$342B
$213K 0.09%
2,723
– –
CELG
44
DELISTED
Celgene Corp
CELG
$204K 0.09%
1,760
-240
-12% -$27.4K
DXCM icon
45
PUT
DexCom
DXCM
$31.3B
$48K 0.02%
+2,400
New +$42.2K
ALNY icon
46
Alnylam Pharmaceuticals
ALNY
$28.9B
– –
-3,300
Closed -$345K
PODD icon
47
Insulet
PODD
$9.65B
– –
-382,599
Closed -$12.8M
STWD icon
48
Starwood Property Trust
STWD
$5.91B
– –
-280,510
Closed -$6.82M
BCPC
49
Balchem Corp
BCPC
$5.75B
– –
-26,250
Closed -$1.45M
NVDQ
50
DELISTED
Novadaq Technologies Inc.
NVDQ
– –
-176,760
Closed -$2.87M
1
2
3

Similar funds

CIM
Coleford Investment Management Toronto, Ontario, Canada $408M AUM 25.62% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
HWM
HFR Wealth Management Niskayuna, New York $407M AUM 7.81% 1-Year Est. Return
QCI
Quaker Capital Investments Mount Lebanon, Pennsylvania $409M AUM 61.78% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
PCP
Perbak Capital Partners London, United Kingdom $406M AUM 17.25% 1-Year Est. Return
RH
RenaissanceRe Holdings Pembroke, Bermuda $406M AUM 2.74% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Rothschild Capital Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Rothschild Capital Partners held 52 positions worth $232M, up 3.6% from $224M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Rothschild Capital Partners's Q2 2015 filing shows 11 new, 12 increased, 16 reduced and 6 closed positions. Its largest new stake was Cardiovascular Systems, Inc.: 203,715 shares worth $5.39M. The largest sale was Insulet, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 30% a quarter earlier, followed by Technology and Communication Services.

  • Rothschild Capital Partners's largest Q2 2015 buy was Cardiovascular Systems, Inc.: 203,715 shares worth $5.39M.
  • Rothschild Capital Partners added most to State Street SPDR S&P Regional Banking ETF in Q2 2015, an estimated $4.78M increase.
  • Rothschild Capital Partners's biggest Q2 2015 reduction was Thermo Fisher Scientific, cutting an estimated $5.44M.
  • Rothschild Capital Partners fully exited Insulet in Q2 2015, selling an estimated $12.8M.
  • Rothschild Capital Partners's ten largest holdings make up 52% of its $232M portfolio in Q2 2015.
  • Rothschild Capital Partners opened 11 new positions and closed 6 in Q2 2015.
  • Rothschild Capital Partners's portfolio value rose 3.6% quarter-over-quarter to $232M.

Based on Rothschild Capital Partners's 13F filing for Q2 2015, filed 31 Jul 2015.